you will get information about the staphyloma, its types, its etiology, its pathogenesis and its treatment.
you will know about the clinical types of staphyloma in detailed such as anterior staphyloma, posterior staphyloma, equatorial staphyloma, ciliary staphyloma, and Intercalary staphyloma.
“An ENT disease with an ophthalmic manifestation”
Orbital cellulitis (OC) is an inflammatory process that involves the tissues located posterior to the orbital septum within the bony orbit, but the term generally is used to describe infectious inflammation.
It manifests with erythema and edema of the eyelids, vision loss, fever, headache, proptosis, chemosis, and diplopia.
OC usually originates from sinus infection, infection of the eyelids or face, and even hematogenous spread from distant locations.
OC is an uncommon condition that can affect all age groups but is more frequent in the pediatric population.
Simple eye education for EHW, Ophthalmic eye student, school eye education & first - second year optometry students only .
common eye lid inflammatory conditions .
stye or hordeolum ( external / internal hordeolum ), lid abscess , chalazion or mebomian retention cyst, accessory lacrimal glands , lacrimal gland etc...
you will get information about the staphyloma, its types, its etiology, its pathogenesis and its treatment.
you will know about the clinical types of staphyloma in detailed such as anterior staphyloma, posterior staphyloma, equatorial staphyloma, ciliary staphyloma, and Intercalary staphyloma.
“An ENT disease with an ophthalmic manifestation”
Orbital cellulitis (OC) is an inflammatory process that involves the tissues located posterior to the orbital septum within the bony orbit, but the term generally is used to describe infectious inflammation.
It manifests with erythema and edema of the eyelids, vision loss, fever, headache, proptosis, chemosis, and diplopia.
OC usually originates from sinus infection, infection of the eyelids or face, and even hematogenous spread from distant locations.
OC is an uncommon condition that can affect all age groups but is more frequent in the pediatric population.
Simple eye education for EHW, Ophthalmic eye student, school eye education & first - second year optometry students only .
common eye lid inflammatory conditions .
stye or hordeolum ( external / internal hordeolum ), lid abscess , chalazion or mebomian retention cyst, accessory lacrimal glands , lacrimal gland etc...
Glaucoma is a disease provoked by the buildup of intraocular pressure (IOP) within the eye. The buildup damages the eye's optic nerve, leading to vision loss.
this ppt explains PG level vascular occlusion retinopathies in OPTHALMOLOGY
SOURCE- PARSON DISEASES OF EYE
CONTAINS FUNDOSCOPY AND FFA IMAGES WITH LATEST TREATMENTS
Glaucoma is a group of eye diseases which result in damage to the optic nerve and cause vision loss.
Congenital (Buphthalmos): Congenital glaucoma (CG) is a developmental glaucoma that results from the abnormal development of the aqueous drainage structure, characterized by an elevated intra-ocular pressure, enlargement of globe (buphthalmos), corneal edema and optic nerve cupping, and presenting clinically with the characteristic triad of epiphora, photophobia and blepharospasm.
Glaucoma is one of the leading causes of blindness for people over the age of 60.
Pulmonary embolism (PE) occurs when a blood clot gets lodged in an artery in the lung, blocking blood flow to part of the lung.
Blood clots most often start in the legs and travel up through the right side of the heart and into the lungs. This is called DVT.
However, PE sometimes can occur without any evidence of DVT.
Similar to Subconjunctival hemorrhage by Dr. Michael Duplessie Eye Doctor (19)
Great talk about uveitis anterior uveitis and posterior uveitis for those who may have missed it or are not members of American Academy of Ophthalmology Meeting. Kudos to Dr. Lowder
Presentation about Floppy Iris Syndrome by David Chang. Excellent talk and worth a read. Posting it for those who may not be members of American Academy of Ophthalmology or just missed it
DLK is an uncommon complication after lasik. Various etiological agents have been implicated. Responds well to aggressive treatment and early diagnosis
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Subconjunctival hemorrhage by Dr. Michael Duplessie Eye Doctor
1. Michael Duplessie, MD
Taiba Hospital
Department of Ophthalmology
Road No 3,
SabahAl Salem
965-25529019
COME SEE US, THEN SEE THE WORLD
SUBCONJUNCTIVAL
HEMORRHAGE
Associated with ocular rubbing
Common in allergy patients
A reason to have your blood pressure checked
2. SUBCONJUNCTIVAL HEMORRHAGE
A subconjunctival hemorrhage occurs
when a small blood vessel under the con-
junctiva [white part of the eye] breaks and
bleeds.
It may occur spontaneously or from
eye rubbing, coughing, heavy lifting, strain-
ing at the bathroom, or vomiting. In some
cases, it may develop following eye surgery
or trauma.
Subconjunctival hemorrhage tends to
be more common among those with di-
abetes and hypertension. Lastly, it is very
common in individuals on blood thinners.
While it may look frightening, a
subconjunctival hemorrhage is essentially
harmless. The blood becomes trapped
underneath the clear conjunctival tissue,
much like a bruise. The blood is visible be-
cause it shows through the thin, clear con-
junctiva. The blood naturally absorbs with-
in one to three weeks and no treatment is
required.
Signs and Symptoms
Red, bloody patch on the white of the
eye
Painless
No change in vision
Detection and Diagnosis
Most patients notice the subconjunctival
hemorrhage when looking in the mirror, or
friend or family member points it out.
Treatment
Although it may look like an emergency,
a subconjunctival hemorrhage does not
affect the vision and no treatment is
required. Lubricating drops can be used for
an ocular discomfort. It is suggested that
all patients with subconjunctival
hemorrhages and on blood thinners get
blood to evaluate their blood clotting
ability.